Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Joe DePinto from McKesson discussed the challenges facing cell and gene therapies, particularly around reimbursement, and ...

Investing in the specialist workforce and overcoming access barriers is essential to successful delivery of this therapy in the NHS, write Jessie Enakhumhe and Yasmin Sheikh Casgevy, or exagamglogene ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...

QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene ...

Explore gene therapy advancements with Chromatin Bioscience's innovative chromatinLENS platform for safer, more effective treatments.

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic code. The company is using this to develop therapies for rare diseases and ...

Opportunities to implement AI across the entire R&D pipeline The gene therapy development process requires engagement with a large network of partners, including large pharma, small and mid-size ...